Charlotte Brix Andersson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Charlotte Brix Andersson has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Jesper Padkær Petersen
Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
3 shared publications - Søren Paaske Johnsen
Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
3 shared publications - Ulrik Schiøler Kesmodel
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
3 shared publications - Anna Juliane Marsian Aabakke
Department of Obstetrics and Gynecology Copenhagen University Hospital‐Holbæk Holbæk Denmark
2 shared publications Birgitte Henriksen
Department Obstetrics and Gynecology University Hospital of Southern Denmark – Kolding Kolding Denmark
2 shared publicationsElisabeth Rønneberg
Department of Obstetrics and Gynecology Copenhagen University Hospital—Herlev and Gentofte Herlev Denmark
2 shared publications
Latest Publications
- 1 August 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (8) , e2427604
Umbilical Cord pH Levels and Neonatal Morbidity and Mortality
Umbilical cord blood pH (UC-pH) measurement is used to identify infants exposed to intrapartum hypoxia and acidosis. Severe metabolic acidosis is associated with an increased risk of developing hypoxic-ischemic encephalopathy (HIE), potentially leading to lifelong disabilities or death.1,2 Additionally, severe intrapartum hypoxia can result in multiorgan injury, affecting the heart, lungs, and kidneys.3 Immediate recognition of severe acidosis after birth is essential for closer observation and timely intervention, and in case of HIE, to provide therapeutic hypothermia aimed at preventing the second phase of brain injury that occurs 6 to 15 hours after birth.4-6
- 1 August 2024
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 7 (8) , e2427604
Umbilical Cord pH Levels and Neonatal Morbidity and Mortality
Umbilical cord blood pH (UC-pH) measurement is used to identify infants exposed to intrapartum hypoxia and acidosis. Severe metabolic acidosis is associated with an increased risk of developing hypoxic-ischemic encephalopathy (HIE), potentially leading to lifelong disabilities or death.1,2 Additionally, severe intrapartum hypoxia can result in multiorgan injury, affecting the heart, lungs, and kidneys.3 Immediate recognition of severe acidosis after birth is essential for closer observation and timely intervention, and in case of HIE, to provide therapeutic hypothermia aimed at preventing the second phase of brain injury that occurs 6 to 15 hours after birth.4-6
- Open Access
- 10 April 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (7) , 854-864
Implementation of universal umbilical cord pH analysis in Denmark. A national register‐based study
Introduction: Umbilical cord blood gas analysis provides information about intrapartum hypoxia and is considered an important measure of quality in maternity care. Universal measurement of umbilical cord pH (UC‐pH), as part of umbilical cord blood gas analysis, has been recommended in Denmark since 2009. The recommendation is that UC‐pH is measured from the umbilical cord artery (pHUA) and vein (pHUV). The aim of this study was to evaluate the national implementation of universal measurement of UC‐pH.Material and methods: The study consisted of two parts. First, an evaluation of the implementation, that is, the proportion of births with measured UC‐pH since the recommendation was introduced. Second, an evaluation of the cases in which UC‐pH was missing. This analysis only involved births with gestational age ≥35 + 0 weeks.Results: In the period 2009 to 2018 there were 560 889 singleton, live births with registered gestational age in Denmark. The proportion of births with measured pHUA and pHUV increased from 12.4% in 2009 to 82.8% in 2015 and then declined to 76.9% in 2018 (p < 0.001). When comparing the group with missing pH from one or both vessels to the group with both pHUA and pHUV we found lower occurrence of pregnancy and births complications in the first group, body mass index ≥35 (unadjusted RR: 0.89, 95% CI: 0.85–0.93), pregnancy induced medical conditions (RR: 0.86, 95% CI: 0.84–0.89), fetal distress during birth (RR: 0.77, 95% CI: 0.76–0.79), emergency cesarean section (RR: 0.80, 95% CI: 0.78–0.83) and serious births events (RR: 0.80, 95% CI: 0.74–0.86). In contrast, the occurrence of placental insufficiency (RR: 1.07, 95% CI: 1.03–1.11), small for gestational age (RR: 1.36, 95% CI: 1.30–1.43, for UA and pHUV.Conclusions: The use of UC‐pH measurement has increased markedly in Denmark since universal measurement was recommended in 2009. Missing UC‐pH from one or both vessels was associated with less complicated pregnancies and with small for gestational age, hypothermia treatment and neonatal death.
- 10 April 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (7) , 854-864
Open AccessImplementation of universal umbilical cord pH analysis in Denmark. A national register‐based study
Introduction: Umbilical cord blood gas analysis provides information about intrapartum hypoxia and is considered an important measure of quality in maternity care. Universal measurement of umbilical cord pH (UC‐pH), as part of umbilical cord blood gas analysis, has been recommended in Denmark since 2009. The recommendation is that UC‐pH is measured from the umbilical cord artery (pHUA) and vein (pHUV). The aim of this study was to evaluate the national implementation of universal measurement of UC‐pH.Material and methods: The study consisted of two parts. First, an evaluation of the implementation, that is, the proportion of births with measured UC‐pH since the recommendation was introduced. Second, an evaluation of the cases in which UC‐pH was missing. This analysis only involved births with gestational age ≥35 + 0 weeks.Results: In the period 2009 to 2018 there were 560 889 singleton, live births with registered gestational age in Denmark. The proportion of births with measured pHUA and pHUV increased from 12.4% in 2009 to 82.8% in 2015 and then declined to 76.9% in 2018 (p < 0.001). When comparing the group with missing pH from one or both vessels to the group with both pHUA and pHUV we found lower occurrence of pregnancy and births complications in the first group, body mass index ≥35 (unadjusted RR: 0.89, 95% CI: 0.85–0.93), pregnancy induced medical conditions (RR: 0.86, 95% CI: 0.84–0.89), fetal distress during birth (RR: 0.77, 95% CI: 0.76–0.79), emergency cesarean section (RR: 0.80, 95% CI: 0.78–0.83) and serious births events (RR: 0.80, 95% CI: 0.74–0.86). In contrast, the occurrence of placental insufficiency (RR: 1.07, 95% CI: 1.03–1.11), small for gestational age (RR: 1.36, 95% CI: 1.30–1.43, for UA and pHUV.Conclusions: The use of UC‐pH measurement has increased markedly in Denmark since universal measurement was recommended in 2009. Missing UC‐pH from one or both vessels was associated with less complicated pregnancies and with small for gestational age, hypothermia treatment and neonatal death.
- Open Access
- 25 January 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (3) , 282-293
Risk factors for and pregnancy outcomes after SARS‐CoV‐2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS‐CoV‐2 diagnosis
Introduction: We identified risk factors and outcomes associated with SARS‐CoV‐2 infection in pregnancy in a universally tested population according to disease severity and validated information on SARS‐CoV‐2 during pregnancy in national health registers in Denmark.Material and methods: Cohort study using data from national registers and medical records including all pregnancies between March 1, 2020 and February 28, 2021. We compared women with a validated positive SARS‐CoV‐2 test during pregnancy with non‐infected pregnant women. Risk factors and pregnancy outcomes were assessed by Poisson and Cox regression models and stratified according to disease severity defined by hospital admission status and admission reason (COVID‐19 symptoms or other). Using medical record data on actual period of pregnancy, we calculated predictive values of the SARS‐CoV‐2 diagnosis in pregnancy in the registers.Results: SARS‐CoV‐2 infection was detected in 1819 (1.6%) of 111 185 pregnancies. Asthma was associated with infection (relative risk [RR] 1.63, 95% confidence interval [CI] 1.28–2.07). Risk factors for severe COVID‐19 disease requiring hospital admission were high body mass index (median ratio 1.06, 95% CI 1.04–1.09), asthma (RR 7.47, 95% CI 3.51–15.90) and gestational age at the time of infection (gestational age 28–36 vs < 22: RR 3.53, 95% CI 1.75–7.10). SARS‐CoV‐2‐infected women more frequently had hypertensive disorders in pregnancy (adjusted hazard ratio [aHR] 1.31, 95% CI 1.04–1.64), early pregnancy loss (aHR 1.37, 95% CI 1.00–1.88), preterm delivery before gestational age 28 (aHR 2.31, 95% CI 1.01–5.26), iatrogenically preterm delivery before gestational age 37 (aHR 1.49, 95% CI 1.01–2.19) and small‐for‐gestational age children (aHR 1.28, 95% CI 1.05–1.54). The associations were stronger among women admitted to hospital for any reason. The validity of the SARS‐CoV‐2 diagnosis in relation to pregnancy in the registers compared with medical records showed a negative predictive value of 99.9 (95% CI 99.9–100.0) and a positive predictive value of 82.1 (95% CI 80.4–83.7).Conclusions: Women infected with SARS‐CoV‐2 during pregnancy were at increased risk of hypertensive disorders in pregnancy, early pregnancy loss, preterm delivery and having children small for gestational age. The validity of Danish national registers was acceptable for identification of SARS‐CoV‐2 infection during pregnancy.
- 25 January 2023
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 102 (3) , 282-293
Open AccessRisk factors for and pregnancy outcomes after SARS‐CoV‐2 in pregnancy according to disease severity: A nationwide cohort study with validation of the SARS‐CoV‐2 diagnosis
Introduction: We identified risk factors and outcomes associated with SARS‐CoV‐2 infection in pregnancy in a universally tested population according to disease severity and validated information on SARS‐CoV‐2 during pregnancy in national health registers in Denmark.Material and methods: Cohort study using data from national registers and medical records including all pregnancies between March 1, 2020 and February 28, 2021. We compared women with a validated positive SARS‐CoV‐2 test during pregnancy with non‐infected pregnant women. Risk factors and pregnancy outcomes were assessed by Poisson and Cox regression models and stratified according to disease severity defined by hospital admission status and admission reason (COVID‐19 symptoms or other). Using medical record data on actual period of pregnancy, we calculated predictive values of the SARS‐CoV‐2 diagnosis in pregnancy in the registers.Results: SARS‐CoV‐2 infection was detected in 1819 (1.6%) of 111 185 pregnancies. Asthma was associated with infection (relative risk [RR] 1.63, 95% confidence interval [CI] 1.28–2.07). Risk factors for severe COVID‐19 disease requiring hospital admission were high body mass index (median ratio 1.06, 95% CI 1.04–1.09), asthma (RR 7.47, 95% CI 3.51–15.90) and gestational age at the time of infection (gestational age 28–36 vs < 22: RR 3.53, 95% CI 1.75–7.10). SARS‐CoV‐2‐infected women more frequently had hypertensive disorders in pregnancy (adjusted hazard ratio [aHR] 1.31, 95% CI 1.04–1.64), early pregnancy loss (aHR 1.37, 95% CI 1.00–1.88), preterm delivery before gestational age 28 (aHR 2.31, 95% CI 1.01–5.26), iatrogenically preterm delivery before gestational age 37 (aHR 1.49, 95% CI 1.01–2.19) and small‐for‐gestational age children (aHR 1.28, 95% CI 1.05–1.54). The associations were stronger among women admitted to hospital for any reason. The validity of the SARS‐CoV‐2 diagnosis in relation to pregnancy in the registers compared with medical records showed a negative predictive value of 99.9 (95% CI 99.9–100.0) and a positive predictive value of 82.1 (95% CI 80.4–83.7).Conclusions: Women infected with SARS‐CoV‐2 during pregnancy were at increased risk of hypertensive disorders in pregnancy, early pregnancy loss, preterm delivery and having children small for gestational age. The validity of Danish national registers was acceptable for identification of SARS‐CoV‐2 infection during pregnancy.
- Open Access
- 5 April 2022
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 101 (7) , 840
Risk of complications in late term pregnancies adjusted for induction of labor
- 5 April 2022
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 101 (7) , 840
Open AccessRisk of complications in late term pregnancies adjusted for induction of labor
- Open Access
- 6 December 2021
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 101 (2) , 200-211
Risk of complications in the late vs early days of the 42nd week of pregnancy: A nationwide cohort study
Introduction: Uncertainty remains about the most appropriate timing of induction of labor in late‐term pregnancies. To address this issue, this study aimed to compare the risk of neonatal morbidity and pregnancy‐ and birth‐related complications between gestational age (GA) 41+4–42+0 and GA 41+0–41+3 weeks.Material and methods: This nationwide registry‐based cohort study included singleton births without major congenital malformations, with registered GA, and with intended vaginal delivery at GA 41+0– 42+0 weeks between 2009 and 2018 in Denmark. Logistic regression models were used to estimate the crude risk ratio and adjusted risk ratio (RRA) of neonatal and obstetric adverse outcomes in births at GA 41+4– 42+0 weeks compared with GA 41+0– 41+3 weeks. The results were adjusted for relevant confounders, including induction of labor.Results: A higher incidence of neonatal morbidity and birth complications was observed in births at GA 41+4–42+0 weeks than in births at GA 41+0–41+3 weeks. Neonatal morbidities included an increased risk of low Apgar score (Apgar 0–6 after 5 min; RRA 1.17, 95% confidence interval [CI] 1.01–1.34), meconium aspiration (RRA 1.25, 95% CI 1.06–1.48), need for respiratory support (continuous positive airway pressure; RRA 1.09, 95% CI 1.03–1.15), and a composite outcome of need for comprehensive treatment at a neonatal department or neonatal death (RRA 1.65, 95% CI 1.29–2.11). Birth complications included emergency cesarean section (RRA 1.17, 95% CI 1.14–1.21), severe lacerations (RRA 1.11, 95% Cl 1.04–1.17), and increased blood loss after birth (RRA 1.13, 95% CI 1.06–1.21).Conclusions: Births at GA 41+4–42+0 weeks were associated with an increased risk of neonatal morbidity and birth complications compared with births at GA 41+0–41+3 weeks. The results of this study may aid clinicians in deciding when to recommend induction of labor in late‐term pregnancies.
- 6 December 2021
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 101 (2) , 200-211
Open AccessRisk of complications in the late vs early days of the 42nd week of pregnancy: A nationwide cohort study
Introduction: Uncertainty remains about the most appropriate timing of induction of labor in late‐term pregnancies. To address this issue, this study aimed to compare the risk of neonatal morbidity and pregnancy‐ and birth‐related complications between gestational age (GA) 41+4–42+0 and GA 41+0–41+3 weeks.Material and methods: This nationwide registry‐based cohort study included singleton births without major congenital malformations, with registered GA, and with intended vaginal delivery at GA 41+0– 42+0 weeks between 2009 and 2018 in Denmark. Logistic regression models were used to estimate the crude risk ratio and adjusted risk ratio (RRA) of neonatal and obstetric adverse outcomes in births at GA 41+4– 42+0 weeks compared with GA 41+0– 41+3 weeks. The results were adjusted for relevant confounders, including induction of labor.Results: A higher incidence of neonatal morbidity and birth complications was observed in births at GA 41+4–42+0 weeks than in births at GA 41+0–41+3 weeks. Neonatal morbidities included an increased risk of low Apgar score (Apgar 0–6 after 5 min; RRA 1.17, 95% confidence interval [CI] 1.01–1.34), meconium aspiration (RRA 1.25, 95% CI 1.06–1.48), need for respiratory support (continuous positive airway pressure; RRA 1.09, 95% CI 1.03–1.15), and a composite outcome of need for comprehensive treatment at a neonatal department or neonatal death (RRA 1.65, 95% CI 1.29–2.11). Birth complications included emergency cesarean section (RRA 1.17, 95% CI 1.14–1.21), severe lacerations (RRA 1.11, 95% Cl 1.04–1.17), and increased blood loss after birth (RRA 1.13, 95% CI 1.06–1.21).Conclusions: Births at GA 41+4–42+0 weeks were associated with an increased risk of neonatal morbidity and birth complications compared with births at GA 41+0–41+3 weeks. The results of this study may aid clinicians in deciding when to recommend induction of labor in late‐term pregnancies.
- Open Access
- 31 August 2021
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 100 (11) , 2097-2110
SARS‐CoV‐2 infection in pregnancy in Denmark—characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population‐based cohort study
Introduction: Assessing the risk factors for and consequences of infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) during pregnancy is essential to guide clinical care. Previous studies on SARS‐CoV‐2 infection in pregnancy have been among hospitalized patients, which may have exaggerated risk estimates of severe outcomes because all cases of SARS‐CoV‐2 infection in the pregnant population were not included. The objectives of this study were to identify risk factors for and outcomes after SARS‐CoV‐2 infection in pregnancy independent of severity of infection in a universally tested population, and to identify risk factors for and outcomes after severe infection requiring hospital admission.Material and methods: This was a prospective population‐based cohort study in Denmark using data from the Danish National Patient Register and Danish Microbiology Database and prospectively registered data from medical records. We included all pregnancies between March 1 and October 31, 2020 and compared women with a positive SARS‐CoV‐2 test during pregnancy to non‐infected pregnant women. Cases of SARS‐CoV‐2 infection in pregnancy were both identified prospectively and through register linkage to ensure that all cases were identified and that cases were pregnant during infection. Main outcome measures were pregnancy, delivery, maternal, and neonatal outcomes. Severe infection was defined as hospital admission due to coronavirus disease 2019 (COVID‐19) symptoms.Results: Among 82 682 pregnancies, 418 women had SARS‐CoV‐2 infection during pregnancy, corresponding to an incidence of 5.1 per 1000 pregnancies, 23 (5.5%) of which required hospital admission due to COVID‐19. Risk factors for infection were asthma (odds ratio [OR] 2.19, 95% CI 1.41–3.41) and being foreign born (OR 2.12, 95% CI 1.70–2.64). Risk factors for hospital admission due to COVID‐19 included obesity (OR 2.74, 95% CI 1.00–7.51), smoking (OR 4.69, 95% CI 1.58–13.90), infection after gestational age (GA) 22 weeks (GA 22–27 weeks: OR 3.77, 95% CI 1.16–12.29; GA 28–36 weeks: OR 4.76, 95% CI 1.60–14.12), and having asthma (OR 4.53, 95% CI 1.39–14.79). We found no difference in any obstetrical or neonatal outcomes.Conclusions: Only 1 in 20 women with SARS‐CoV‐2 infection during pregnancy required admission to hospital due to COVID‐19. Risk factors for admission comprised obesity, smoking, asthma, and infection after GA 22 weeks. Severe adverse outcomes of SARS‐CoV‐2 infection in pregnancy were rare.
- 31 August 2021
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 100 (11) , 2097-2110
Open AccessSARS‐CoV‐2 infection in pregnancy in Denmark—characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population‐based cohort study
Introduction: Assessing the risk factors for and consequences of infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) during pregnancy is essential to guide clinical care. Previous studies on SARS‐CoV‐2 infection in pregnancy have been among hospitalized patients, which may have exaggerated risk estimates of severe outcomes because all cases of SARS‐CoV‐2 infection in the pregnant population were not included. The objectives of this study were to identify risk factors for and outcomes after SARS‐CoV‐2 infection in pregnancy independent of severity of infection in a universally tested population, and to identify risk factors for and outcomes after severe infection requiring hospital admission.Material and methods: This was a prospective population‐based cohort study in Denmark using data from the Danish National Patient Register and Danish Microbiology Database and prospectively registered data from medical records. We included all pregnancies between March 1 and October 31, 2020 and compared women with a positive SARS‐CoV‐2 test during pregnancy to non‐infected pregnant women. Cases of SARS‐CoV‐2 infection in pregnancy were both identified prospectively and through register linkage to ensure that all cases were identified and that cases were pregnant during infection. Main outcome measures were pregnancy, delivery, maternal, and neonatal outcomes. Severe infection was defined as hospital admission due to coronavirus disease 2019 (COVID‐19) symptoms.Results: Among 82 682 pregnancies, 418 women had SARS‐CoV‐2 infection during pregnancy, corresponding to an incidence of 5.1 per 1000 pregnancies, 23 (5.5%) of which required hospital admission due to COVID‐19. Risk factors for infection were asthma (odds ratio [OR] 2.19, 95% CI 1.41–3.41) and being foreign born (OR 2.12, 95% CI 1.70–2.64). Risk factors for hospital admission due to COVID‐19 included obesity (OR 2.74, 95% CI 1.00–7.51), smoking (OR 4.69, 95% CI 1.58–13.90), infection after gestational age (GA) 22 weeks (GA 22–27 weeks: OR 3.77, 95% CI 1.16–12.29; GA 28–36 weeks: OR 4.76, 95% CI 1.60–14.12), and having asthma (OR 4.53, 95% CI 1.39–14.79). We found no difference in any obstetrical or neonatal outcomes.Conclusions: Only 1 in 20 women with SARS‐CoV‐2 infection during pregnancy required admission to hospital due to COVID‐19. Risk factors for admission comprised obesity, smoking, asthma, and infection after GA 22 weeks. Severe adverse outcomes of SARS‐CoV‐2 infection in pregnancy were rare.
- Open Access
- 1 October 2016
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 8, 595-599
The Danish National Quality Database for Births
Aim of the database: The aim of the Danish National Quality Database for Births (DNQDB) is to measure the quality of the care provided during birth through specific indicators. Study population: The database includes all hospital births in Denmark. Main variables: Anesthesia/pain relief, continuous support for women in the delivery room, lacerations (third and fourth degree), cesarean section, postpartum hemorrhage, establishment of skin-to-skin contact between the mother and the newborn infant, severe fetal hypoxia (proportion of live-born children with neonatal hypoxia), delivery of a healthy child after an uncomplicated birth, and anesthesia in case of cesarean section. Descriptive data: Data have been collected since 2010. As of August 2015, data on women and children representing 269,597 births and 274,153 children have been collected. All data for the DNQDB is collected from the Danish Medical Birth Registry. Registration to the Danish Medical Birth Registry is mandatory for all maternity units in Denmark. During the 5 years, performance has improved in the areas covered by the process indicators and for some of the outcome indicators. Conclusion: Measuring quality of care during childbirth has inspired and enabled staff to attend to the quality of the care they provide and has led to improvements in most of the areas covered.
- 1 October 2016
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 8, 595-599
Open AccessThe Danish National Quality Database for Births
Aim of the database: The aim of the Danish National Quality Database for Births (DNQDB) is to measure the quality of the care provided during birth through specific indicators. Study population: The database includes all hospital births in Denmark. Main variables: Anesthesia/pain relief, continuous support for women in the delivery room, lacerations (third and fourth degree), cesarean section, postpartum hemorrhage, establishment of skin-to-skin contact between the mother and the newborn infant, severe fetal hypoxia (proportion of live-born children with neonatal hypoxia), delivery of a healthy child after an uncomplicated birth, and anesthesia in case of cesarean section. Descriptive data: Data have been collected since 2010. As of August 2015, data on women and children representing 269,597 births and 274,153 children have been collected. All data for the DNQDB is collected from the Danish Medical Birth Registry. Registration to the Danish Medical Birth Registry is mandatory for all maternity units in Denmark. During the 5 years, performance has improved in the areas covered by the process indicators and for some of the outcome indicators. Conclusion: Measuring quality of care during childbirth has inspired and enabled staff to attend to the quality of the care they provide and has led to improvements in most of the areas covered.